English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Thrombin is the key enzyme of fibrin formation in the blood coagulation cascade. Thrombin is released by the hydrolysis of prothrombinase which is generated from factor Xa and factor Va in the presence of calcium ion and phospholipid. The inhibition of thrombin is of therapeutic interest in blood clot treatment. Currently, potent thrombin inhibitors of (R)-3- amidinophenylalanine, derived from benzamidine-containing amino acid, have been developed so far. In order to quantitatively express a relationship between chemical structures and inhibition constants (Ki with thrombin enzyme in a data set of (R)-3-amidinophenylalanine inhibitors), we developed a quantitative structure-activity relationship (QSAR) modeling from a group of 60 (R)-3- amidinophenylalanine inhibitors. Methods: A database containing chemical structures of 60 inhibitors and their Ki values was put into molecular operating environment (MOE) 2008.10 software, and the two-dimensional (2D) physicochemical descriptors were numerically calculated. After removing the irrelevant descriptors, a QSAR modeling was developed from the 2D-descriptors and Ki values by using the partial least squares (PLS) regression method. Results: The results showed that the hydrophobic property, reflected through n-octanol/water partition coefficient (P) of a drug molecule, contributes mainly to Ki values with thrombin.The statistic parameters that give the information about the goodness of fit of a 2D-QSAR model (such as squared correlation coefficient of R2 = 0.791, root mean square error (RMSE) = 0.443, cross-validated Q2 cv = 0.762, and cross-validated RMSEcv = 0.473) were statistically obtained for a training set (60 inhibitors). The R2 and RMSE values were obtained by using a developed model for the testing set (9 inhibitors) ; the total set has statistically significant parameters. Furthermore, the 2D-QSAR modeling was also applied to predict the Ki values of the 69 inhibitors. A linear relationship was found between the experimental and predicted pKi values of the inhibitors. Conclusion: The results support the promising application of established 2D-QSAR modeling in the prediction and design of new (R)-3-amidinophenylalanine candidates in the pharmaceutical industry.

Hydrophobic Property of (R)-3 Amidinophenylalanine Inhibitors Contributes to their Inhibition Constants with Thrombin Enzyme